VOLULYTE

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, Hong Kong, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore

Active ingredients

The drug VOLULYTE contains a combination of these active pharmaceutical ingredients (APIs):

1 Poly (0-2-hydroxyethyl) starch (M.W 200000) UNII 1GVO236S58 - HYDROXYETHYL STARCH 130/0.4

Read about HAES

2 Sodium acetate trihydrate UNII 4550K0SC9B - SODIUM ACETATE

Read about Sodium acetate

3 Sodium chloride UNII 451W47IQ8X - SODIUM CHLORIDE

Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue. Read about Sodium chloride

4 Potassium chloride UNII 660YQ98I10 - POTASSIUM CHLORIDE

Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism. Read about Potassium chloride

5 Magnesium chloride hexahydrate UNII 02F3473H9O - MAGNESIUM CHLORIDE

Read about Magnesium chloride

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B05AA07	Hydroxyethylstarch	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products → B05AA Blood substitutes and plasma protein fractions
Discover more medicines within B05AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1223323, 1223334, 1223345, 1223356, 1223367, 1223378, 1223389, 1223390, 1325304, 1325315
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 70228
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 155885
Country: HK	Department of Health Drug Office	Identifier(s): 58087
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1022178, 1022179, 1022180, 1022181, 1022182, 1022183, 1022184, 1022185, 1083696, 1083697, 1083698, 1083699, 1083700, 1083701, 1083702
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 86665
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15246
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100115540
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W54129003, W54129004, W54129005, W54129006, W54129007, W54129010, W54129011, W54129012, W54129013, W54129014, W54129015, W54129016, W54129017, W54129018, W54129019
Country: SG	Health Sciences Authority	Identifier(s): 13893P